Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stellate Ganglion Block to Treat Long COVID-19 Syndrome, A 41 Patient Retrospective Cohort Study

NCT05812209 is registered in ClinicalTrials.gov with Metamorphosis LTD as lead sponsor.

NCT NCT05812209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05812209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stellate Ganglion Block to Treat Long COVID-19 Syndrome, A 41 Patient Retrospective Cohort Study
Lead sponsor
Metamorphosis LTD
Phase
Observational
Overall status
Completed
Start date
September 1, 2022
Completion date
December 31, 2022
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anosmia, brain fog, cough, dizziness, dysautonomia, dysgeusia, fatigue post viral, long covid, long covid19, menstrual cycle abnormal, muscle pain, pain, post acute covid-19 syndrome, post-covid-19 syndrome, shortness of breath